Exome Survey and Candidate Gene Re-Sequencing Identifies Novel Exstrophy Candidate Genes and Implicates LZTR1 in Disease Formation

Background: The bladder exstrophy-epispadias complex (BEEC) is a spectrum of congenital abnormalities that involves the abdominal wall, the bony pelvis, the urinary tract, the external genitalia, and, in severe cases, the gastrointestinal tract as well. Methods: Herein, we performed an exome analysis of case-parent trios with cloacal exstrophy (CE), the most severe form of the BEEC. Furthermore, we surveyed the exome of a sib-pair presenting with classic bladder exstrophy (CBE) and epispadias (E) only. Moreover, we performed large-scale re-sequencing of CBE individuals for novel candidate genes that were derived from the current exome analysis, as well as for previously reported candidate genes within the CBE phenocritical region, 22q11.2. Results: The exome survey in the CE case-parent trios identified two candidate genes harboring de novo variants (NR1H2, GKAP1), four candidate genes with autosomal-recessive biallelic variants (AKR1B10, CLSTN3, NDST4, PLEKHB1) and one candidate gene with suggestive uniparental disomy (SVEP1). However, re-sequencing did not identify any additional variant carriers in these candidate genes. Analysis of the affected sib-pair revealed no candidate gene. Re-sequencing of the genes within the 22q11.2 CBE phenocritical region identified two highly conserved frameshift variants that led to early termination in two independent CBE males, in LZTR1 (c.978_985del, p.Ser327fster6) and in SLC7A4 (c.1087delC, p.Arg363fster68). Conclusions: According to previous studies, our study further implicates LZTR1 in CBE formation. Exome analysis-derived candidate genes from CE individuals may not represent a frequent indicator for other BEEC phenotypes and warrant molecular analysis before their involvement in disease formation can be assumed.

[1]  Jairo Navarro Gonzalez,et al.  The UCSC Genome Browser database: 2023 update , 2022, Nucleic Acids Res..

[2]  H. Reutter,et al.  Genetic Counseling for Bladder Exstrophy-Epispadias Complex , 2021, European Journal of Pediatric Surgery.

[3]  M. Westerfield,et al.  Zebrafish information network, the knowledgebase for Danio rerio research , 2021, bioRxiv.

[4]  D. Nickerson,et al.  Exome sequencing of child–parent trios with bladder exstrophy: Findings in 26 children , 2021, American journal of medical genetics. Part A.

[5]  T. Nishinaka,et al.  The Role of AKR1B10 in Physiology and Pathophysiology , 2021, Metabolites.

[6]  J. Srovnal,et al.  MLPA analysis of 32 foetuses with a congenital heart defect and 1 foetus with renal defects - pilot study. The significant frequency rate of presented pathological CNV. , 2021, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[7]  J. Shendure,et al.  CADD-Splice—improving genome-wide variant effect prediction using deep learning-derived splice scores , 2021, Genome Medicine.

[8]  A. V. Anagnostopoulos,et al.  Mouse Genome Database (MGD): Knowledgebase for mouse–human comparative biology , 2020, Nucleic Acids Res..

[9]  Peer Bork,et al.  SMART: recent updates, new developments and status in 2020 , 2020, Nucleic Acids Res..

[10]  I. V. van Rooij,et al.  SLC20A1 Is Involved in Urinary Tract and Urorectal Development , 2020, Frontiers in Cell and Developmental Biology.

[11]  Huanming Yang,et al.  An atlas of the protein-coding genes in the human, pig, and mouse brain , 2020, Science.

[12]  Stephen Burgess,et al.  PhenoScanner V2: an expanded tool for searching human genotype–phenotype associations , 2019, Bioinform..

[13]  D. Nilsson,et al.  Further support linking the 22q11.2 microduplication to an increased risk of bladder exstrophy and highlighting LZTR1 as a candidate gene , 2019, Molecular genetics & genomic medicine.

[14]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[15]  Giulio Superti-Furga,et al.  LZTR1 is a regulator of RAS ubiquitination and signaling , 2018, Science.

[16]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[17]  Evan Bolton,et al.  Database resources of the National Center for Biotechnology Information , 2017, Nucleic Acids Res..

[18]  James N. Hughes,et al.  NAD Deficiency, Congenital Malformations, and Niacin Supplementation , 2017, The New England journal of medicine.

[19]  Craig S. Wong,et al.  Genetic Drivers of Kidney Defects in the DiGeorge Syndrome , 2017, The New England journal of medicine.

[20]  Steve D. M. Brown,et al.  High-throughput discovery of novel developmental phenotypes , 2017 .

[21]  Stephen Burgess,et al.  PhenoScanner: a database of human genotype–phenotype associations , 2016, Bioinform..

[22]  J. Thüroff,et al.  Sexual Function, Social Integration and Paternity of Males with Classic Bladder Exstrophy following Urinary Diversion. , 2016, The Journal of urology.

[23]  G. Yamada,et al.  Genetics of Bladder-Exstrophy-Epispadias Complex (BEEC): Systematic Elucidation of Mendelian and Multifactorial Phenotypes , 2015, Current genomics.

[24]  D. Valle,et al.  GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.

[25]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[26]  Akash Kumar,et al.  MIPgen: optimized modeling and design of molecular inversion probes for targeted resequencing , 2014, Bioinform..

[27]  M. Nöthen,et al.  Classic bladder exstrophy: Frequent 22q11.21 duplications and definition of a 414 kb phenocritical region. , 2014, Birth defects research. Part A, Clinical and molecular teratology.

[28]  D. Wood,et al.  Reproductive outcomes in women with classic bladder exstrophy: an observational cross-sectional study. , 2012, American journal of obstetrics and gynecology.

[29]  L. Pasquier,et al.  Utero-vaginal aplasia (Mayer-Rokitansky-Küster-Hauser syndrome) associated with deletions in known DiGeorge or DiGeorge-like loci , 2011, Orphanet journal of rare diseases.

[30]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[31]  M. Nöthen,et al.  Microduplications at 22q11.21 are associated with non-syndromic classic bladder exstrophy. , 2010, European journal of medical genetics.

[32]  H. Reutter,et al.  The Exstrophy-epispadias complex , 2009, Orphanet Journal of Rare Diseases.

[33]  S. Boyadjiev,et al.  Bladder exstrophy-epispadias complex. , 2009, Birth defects research. Part A, Clinical and molecular teratology.

[34]  L. Qi,et al.  Concordance analyses of twins with bladder exstrophy–epispadias complex suggest genetic etiology , 2007, American journal of medical genetics. Part A.

[35]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[36]  J. Carey Exstrophy of the cloaca and the OEIS complex: one and the same. , 2001, American journal of medical genetics.

[37]  E. Bermejo,et al.  Exstrophy of the cloaca and exstrophy of the bladder: two different expressions of a primary developmental field defect. , 2001, American journal of medical genetics.

[38]  J. Gearhart,et al.  The outcome of patients with classic bladder exstrophy in adult life. , 1996, The Journal of urology.

[39]  H. Lepor,et al.  The inheritance of the exstrophy-epispadias complex. , 1984, The Journal of urology.

[40]  C. Carter,et al.  A family study of bladder exstrophy. , 1980, Journal of medical genetics.

[41]  K. Racké,et al.  Analysis of the genomic organization of the human cationic amino acid transporters CAT-1, CAT-2 and CAT-4 , 2001, Amino Acids.